Centrecourt - Investor Profile and Portfolio

Cellavision develops and markets solutions for digital microscopy. Its proprietary platforms improve manual microscopy through automatic analyzers that use a combination if digital imaging, artificial intelligence and IT support. The company specializes in hematology and has analytic solutions for the differential diagnoses for peripheral blood smears, advanced RBC analyses and other body fluid smears.

Developer of probiotic food supplements for adults and babies. The company uses the probiotic bacteria Lactobacillus reuteri and a line of engineering to develop probiotic products for consumer needs. The product line inlcudes Protectis Vitamin D drops for child care and gut health and Vitamin D chewable tablets for adult gastrointestinal health.

Provider of biometric identity verification software and physical access control. The company offers software solutions for fingerprint, face, and palm recognition. It provides visitor management and biometric access control systems. The company's products enhance security and usability across various devices.

Provider of molecular diagnostic kits for diagnosis and monitoring of viral infections. Specifically, the company's area of expertise is in assays that measure reverse transcriptase activity. Its flagship product ExaVir Load is an RT-PCR assay for monitoring viral load in HIV+ patients. Cavidi is also developing a solution for monitoring viral resistance to HIV drugs. Other products in the company's portfolio include diagnostic kits for the detection of lentiviruses, C-type retroviruses, Mn and/or Mg dependent retroviruses, and xenotropic murine leukemia virus-related virus.